Halozyme to license drug delivery tech to Roche, Bristol-Myers Ruby Khatun Khatun16 Sept 2017 9:55 AM ISTU.S. drugmaker Halozyme Therapeutics Inc said on Thursday it would license its drug delivery technology to Bristol-Myers Squibb Co and Swiss drugmaker...
Challenge of Allergan tribal patent deal in uncharted legal territory Ruby Khatun Khatun16 Sept 2017 9:35 AM ISTAs generic drug manufacturers are gearing up to argue that a deal Allergan Plc made with a Native American tribe to shield patents from administrative...
Impressed FDA panel unanimously recommends GSK shingles vaccine Ruby Khatun Khatun16 Sept 2017 9:15 AM ISTA U.S. Food and Drug Administration (FDA) advisory panel on Wednesday voted 11-0 that the safety and efficacy of GlaxoSmithKline’s Shingrix shingles...
Lupin gets USFDA nod to market generic anti-bacterial drug Ruby Khatun Khatun15 Sept 2017 10:46 AM ISTNew Delhi: Drug maker Lupin on Wednesday said it has received US health regulator's nod to market generic version of Flagyl tablets, a drug used to...
Sanofi indicates dupilumab could be used to treat nasal polyps Ruby Khatun Khatun15 Sept 2017 10:17 AM ISTPARIS: Sanofi’s chief executive said that its key drug dupilumab could possibly be used to treat nasal polyps as well as eczema and asthma.The FDA...
Mylan says Allergan misusing tribal sovereignty in patent dispute Ruby Khatun Khatun15 Sept 2017 9:56 AM ISTNEW YORK: Generic drugmaker Mylan NV alleged in a court filing that rival Allergan Plc is trying to take advantage of Native American sovereignty to...
Novartis says biosimilar rituximab accepted for review by FDA Ruby Khatun Khatun15 Sept 2017 9:26 AM ISTZURICH: Novartis AG said on Tuesday its biosimilar rituximab to treat blood cancers and immunological diseases such as rheumatoid arthritis were...
Pharma Bro ordered jailed for online bounty on Hillary Clintons hair Ruby Khatun Khatun14 Sept 2017 10:53 AM ISTA U.S. judge on Wednesday ordered Martin Shkreli to be jailed while he awaits sentencing for securities fraud, citing a Facebook post in which the...
Medtronic announces voluntary recall of Diabetes Infusion Sets MiniMed worldwide Ruby Khatun Khatun14 Sept 2017 10:37 AM ISTDUBLIN: Medtronic plc announced that it has started to inform patients worldwide of a voluntary recall of specific lots of infusion sets used with all...
Johnson and Johnson arm Janssen to discontinue Hepatitis C development program Ruby Khatun Khatun14 Sept 2017 10:02 AM ISTCORK, Ireland: Janssen Sciences Ireland UC (Janssen), announced a strategic decision to discontinue further development of the investigational...
US tribal patent deal could have big impact on generic drug market Ruby Khatun Khatun14 Sept 2017 9:45 AM ISTA groundbreaking deal between Allergan Plc and a Native American tribe to shield the company's patents in administrative proceedings could also be...
Bristols drug cocktail cuts kidney cancer death risk 37 percent Ruby Khatun Khatun14 Sept 2017 9:25 AM ISTMADRID: A combination of two Bristol-Myers Squibb immunotherapy drugs cut the risk of death by 37 percent in a key group of kidney cancer patients,...
